Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
This study was conducted to determine the safety, tolerance, pharmacokinetics and antiviral activity of val-mCyd at doses ranging from 50 mg to 800 mg per day.
Epistemonikos ID: 64d692ba7e8dd7d297465f929ddfb0afa802b2d5
First added on: May 04, 2024